Brii Biosciences Unveils BRiSC siRNA Discovery Platform
Brii Biosciences unveiled its BRiSC platform to advance discovery and development of dual-targeting siRNA medicines, initially focused on prevalent metabolic dysfunctions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.